South Surrey · Private pay · Physician-led

Measure what matters. Improve what can change. Measure it again.

A physician-led healthspan platform combining deep diagnostics, evidence-graded interpretation, targeted intervention and longitudinal proof of change.

  • 212+ measures at launch
  • 8 core domains
  • Evidence-graded A / B / C
  • Recurring by design

212

itemized measures at launch

145

laboratory biomarkers

67

physiological + functional

120

graded A — established

THE OPPORTUNITY

The investment thesis

A large gap in care

Traditional medicine is optimized for disease thresholds and episodic care. Consumer wellness is often attractive but clinically fragmented. BetterHealth365 occupies the middle: rigorous medicine plus measurable optimization.

Recurring by design

The commercial product is not a one-time executive physical. Baseline measurement leads to intervention, repeat testing, trajectory reporting and long-term membership.

Asset-light first

Own the clinical operating system and high-utilization diagnostics. Partner for imaging, DEXA, specialist care and expensive low-utilization infrastructure until demand supports ownership.

The moat is the measurement + interpretation + intervention + longitudinal outcome dataset.

CORE INTELLECTUAL PROPERTY · WORKING DEMONSTRATION

The Healthspan Profile

A transparent scoring architecture, not a black-box “biological age”. Every domain score resolves into four separately stated layers, so a clinician can see exactly what produced it. Select a domain to open it.

PATIENT VIEW · MONTH 18 OF LONGITUDINAL RECORDINTERACTIVE

LAYER 1

Clinical / reference status

A1C 5.4% — below the 5.7% prediabetes threshold. Fasting insulin normal by conventional reference range.

LAYER 2

BH365 optimization target

Preferred zone A1C 5.0–5.4%, fasting insulin < 60 pmol/L, HOMA-IR < 1.5, visceral adipose < 100 cm². Stated separately from diagnostic thresholds.

LAYER 3

Percentile

48th

Age and sex norms available for A1C and visceral adiposity.

LAYER 4

Trajectory

58 → 64 (+6)

Change against this patient’s own baseline over 18 months — the most intuitive proof of improvement.

HbA1c

% · baseline 6.1 → month 18 5.4 · toward target · Grade A

5.45.65.96.1M0M6M12M185.4 %

Illustrative UI only — composite example, not patient data.

LONGITUDINAL FLYWHEEL

The product is the trajectory

01

MEASURE

212+ measures

02

INTERPRET

domain profile

03

INTERVENE

protocol + network

04

MONITOR

wearables + adherence

05

RE-MEASURE

repeat diagnostics

06

RETAIN

membership + data

Recurring value is created by demonstrated change — not by repeating the same executive physical.

COMMERCIAL ARCHITECTURE · WORKING DEMONSTRATION

Tiered diagnostics create accessible entry and increasing depth

Select a tier to see what it includes, how often it repeats, and who it is built for.

Tier

RANGE · $5,900

Repeat cadence

Annual + 6-month interim

Positioning

optimization

Measurement

  • Everything in Core
  • Maximal CPET with VO2max and VT1/VT2
  • Pharmacogenomics
  • Vascular testing (PWV, central pressure)
  • Computerized cognition
  • A continuous glucose monitoring period
  • Posturography and balance

Cadence and review

  • Annual full assessment with a 6-month interim panel
  • Two physician reviews per year
  • Trajectory report against personal baseline

Built for

  • 45–65 optimization
  • Athletes and performance
  • Cardiometabolic risk carriers

Current planning prices — vendor, lab and imaging contracts remain to be finalized.

WHAT WE MEASURE

A diagnostic platform deeper than bloodwork

145 measures

Blood + molecular

Laboratory biomarkers across cardiometabolic, inflammatory, endocrine, nutritional, neurological, cancer and pharmacogenomic domains.

own / operate

Cardiorespiratory

Maximal CPET, VO2max, VT1/VT2, RER, VE/VCO2, chronotropic response, oxygen pulse and NIRS muscle oxygen extraction.

own + partner

Vascular + cardiac

PWV, central pressure, augmentation index, CIMT/plaque, endothelial testing, resting ECG, exercise ECG and ambulatory monitoring where indicated.

own + partner

Body + function

DEXA, VAT, BMD, grip, sit-to-stand, gait, balance, posturography, movement screening and resting metabolic rate.

phase 1-2

Brain + sensory

Computerized cognition, hearing, speech-in-noise, vision, retinal photography, olfaction; proposed EEG expansion after device review.

continuous

Sleep + recovery

AHI/ODI, actigraphy, sleep efficiency and fragmentation, ECG-grade HRV, CGM and wearable recovery streams.

Continuous streams are not inflated into “thousands of biomarkers”. They form a separate longitudinal layer.

EXAMPLES OF CLOSED-LOOP CARE

From intervention to measurable endpoint

Every protocol maps to specific measurable endpoints, contraindications, monitoring and an evidence grade.

ProgramIntervention pathwayRe-measured endpoints
Metabolic / obesityNutrition + exercise + GLP-1/GIP where indicatedweight · VAT · A1C · CGM · BP
CardiovascularLipid / BP therapy + trainingApoB · BP · PWV · plaque · VO2max
Fitness / performanceTraining prescription + IHHT candidate pathwayVO2max · VT1/VT2 · NIRS · HRV
Brain / cognitionSleep + exercise + cognitive training; TMS when indicatedprocessing speed · memory · sleep · HRV
Balance / healthy agingProprioception training + strength + OT / rehabsway · gait · reaction · sit-to-stand

NEUROSENSORY PLATFORM · WORKING DEMONSTRATION

Balance and proprioception as a diagnostic domain and a device opportunity

An instrumented platform with multi-axis sensors, load cells, adaptive difficulty and clinician-facing longitudinal curves. Select a test condition to see the centre-of-pressure trace it produces.

POSTUROGRAPHY · CENTRE-OF-PRESSURE TRACE · 30 S CAPTUREINTERACTIVE
A/P × M/L · 1 cm grid

Eyes open · firm surface · 95% ellipse 1.4 cm²

MEASURE

sway, symmetry, reaction, recovery

TRAIN

controlled instability with adaptive progression

PROVE

repeatable metrics and performance curves

PROTECT

overhead harness, stop control, travel limits

Illustrative UI only — simulated trace, not patient data. Future IP: sensing, adaptive algorithms, feedback and fall-protection architecture.

EVIDENCE ARCHITECTURE

Clinical governance lets BetterHealth365 move early without overclaiming

Grade A · 120 measures

Established

Validated assay, guideline-supported, clear clinical action. Drives decisions and referrals.

Grade B · 53 measures

Emerging

Validated measurement with growing evidence and evolving actionability. Informs discussion and longitudinal interpretation.

Grade C · 39 measures

Investigational

Used for research and trending. Never the sole basis of a recommendation; consent and governance as applicable.

Optimization targets are stated separately from conventional diagnostic thresholds and tied to the underlying outcome literature.

DEFENSIBILITY

Why this can scale

Protocolized diagnostics

Repeatable acquisition across sites.

Evidence grading

Transparent established versus emerging science.

Healthspan scoring

Proprietary interpretation and trajectory.

Longitudinal dataset

Diagnostics, interventions, adherence and outcomes.

Network economics

Partner delivery reduces fixed-cost burden.

Future device IP

Instrumented balance and proprioception platform.

The moat is not a chamber, a supplement or a test. It is the operating system and the outcome dataset.

PHASED BUILD

Launch asset-light. Add capital only when utilization justifies it.

Phase 1 · South Surrey

  • Physician assessment
  • Core functional diagnostics
  • CPET, HRV, CGM, cognition
  • Wearable integration
  • Prescription treatment
  • Balance prototype
  • Subcontracted allied health
  • Partner DEXA, MRI, advanced imaging

Phase 2 · Advanced

  • IHHT
  • Expanded neurophysiology, EEG after device review
  • More performance diagnostics
  • Selected infusion capability
  • Advanced balance platform
  • TMS partnership where justified
  • Additional in-house diagnostics

Phase 3 · Destination

  • HBOT chambers
  • Photobiomodulation and infrared
  • Whole-body cryotherapy
  • Expanded treatment suites
  • Potential destination-health model
  • International expansion as a separate regulated workstream

GO TO MARKET

South Surrey first. A repeatable clinic model next.

Step 1

Flagship

Launch the private-pay South Surrey site with physician-led assessment, core diagnostics, a partner network and the longitudinal platform.

Step 2

Validate

Prove demand, utilization, retention, intervention adherence, repeat-testing rates and unit economics.

Step 3

Standardize

Codify acquisition protocols, scoring, reporting, treatment pathways, subcontractor standards and the data model.

Step 4

Replicate

Expand through additional clinics, partnerships or licensing once the operating system is proven.

Build the operating system for measurable healthspan improvement.

Measure. Improve. Prove.

BetterHealth365 combines deep measurement, physician interpretation, targeted intervention, continuous monitoring and repeat testing into a recurring private-pay platform. The initial South Surrey clinic is designed to validate the operating model before higher-capital modalities and multi-site expansion.